ARS Pharmaceuticals, Inc. - Common Stock (NQ:SPRY)
9.440
+0.060
(+0.64%)
Streaming Delayed Price
Updated: 12:15 PM EST, Feb 18, 2026
Add to My Watchlist
All News about ARS Pharmaceuticals, Inc. - Common Stock
FDA Rejects EpiPen Alternative - ARS Pharmaceuticals' Allergic Reaction Nasal Spray ↗
September 20, 2023
Via Benzinga
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|